- Home
- INDP vs TTNP Comparison
INDP vs TTNP Comparison
Compare INDP & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- TTNP
- Stock Information
- Founded
- INDP 2000
- TTNP 1991
- Country
- INDP United States
- TTNP United States
- Employees
- INDP N/A
- TTNP 4
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INDP Health Care
- TTNP Health Care
- Exchange
- INDP Nasdaq
- TTNP Nasdaq
- Market Cap
- INDP 5.0M
- TTNP 5.9M
- IPO Year
- INDP N/A
- TTNP 1996
- Fundamental
- Price
- INDP $11.12
- TTNP $4.40
- Analyst Decision
- INDP Strong Buy
- TTNP
- Analyst Count
- INDP 2
- TTNP 0
- Target Price
- INDP $8.50
- TTNP N/A
- AVG Volume (30 Days)
- INDP 689.8K
- TTNP 44.6K
- Earning Date
- INDP 08-11-2025
- TTNP 08-14-2025
- Dividend Yield
- INDP N/A
- TTNP N/A
- EPS Growth
- INDP N/A
- TTNP N/A
- EPS
- INDP N/A
- TTNP N/A
- Revenue
- INDP N/A
- TTNP N/A
- Revenue This Year
- INDP N/A
- TTNP N/A
- Revenue Next Year
- INDP N/A
- TTNP N/A
- P/E Ratio
- INDP N/A
- TTNP N/A
- Revenue Growth
- INDP N/A
- TTNP N/A
- 52 Week Low
- INDP $7.56
- TTNP $3.03
- 52 Week High
- INDP $67.48
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- INDP 98.13
- TTNP 48.35
- Support Level
- INDP $0.31
- TTNP $4.23
- Resistance Level
- INDP $0.71
- TTNP $4.65
- Average True Range (ATR)
- INDP 0.07
- TTNP 0.27
- MACD
- INDP 0.77
- TTNP -0.03
- Stochastic Oscillator
- INDP 99.09
- TTNP 30.67
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.